Divi'S Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-06-2024
- Paid Up Capital ₹ 5.00 M
as on 30-06-2024
- Company Age 37 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 332.16%
(FY 2022)
- Profit 336.59%
(FY 2022)
- Ebitda -346.62%
(FY 2022)
- Net Worth 13.58%
(FY 2022)
- Total Assets 13.65%
(FY 2022)
About Divi'S Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Murali Divi, Satchandra Divi, Swarna Divi, and One other member serve as directors at the Company.
- CIN/LLPIN
U51219TG1987PTC007114
- Company No.
007114
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Divi'S Biotech?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Murali Divi | Director | 22-Jan-1987 | Current |
Satchandra Divi | Director | 20-Aug-1997 | Current |
Swarna Divi | Director | 22-Jan-1987 | Current |
Motaparti Nilima | Director | 05-Jan-2017 | Current |
Financial Performance and Corporate Structure Insights of Divi'S Biotech.
Divi'S Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 332.16% increase. The company also saw a substantial improvement in profitability, with a 336.59% increase in profit. The company's net worth Soared by an impressive increase of 13.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Divi'S Biotech?
In 2021, Divi'S Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Divi's Laboratories LimitedActive 34 years 2 months
Murali Divi, Satchandra Divi and 1 more are mutual person
- Divi's Properties Private LimitedActive 19 years 9 months
Murali Divi, Satchandra Divi and 2 more are mutual person
- Divi's Resorts And Agro Farms Private LimitedActive 16 years 2 months
Murali Divi, Satchandra Divi and 2 more are mutual person
- Avant Garde Ventures LlpActive 5 years 7 months
Satchandra Divi and Motaparti Nilima are mutual person
- Divi's Finvest Private LimitedActive 1 year 4 months
Satchandra Divi and Motaparti Nilima are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Divi'S Biotech?
Unlock and access historical data on people associated with Divi'S Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Divi'S Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Divi'S Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.